OWEN KATEY EINTERZ sold 10.9% of their position (9.62K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $250.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/28/2026ACC: 0001852578-26-000005
Director
Since Mar 2021
-9.62K
Net shares
Net seller
$250.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.62K
Price / share
$26.00
Trade value
$249.99K
% of position
10.9%
8/26/2026
88.25K→78.64K
Total
Net shares
−9.62K
Net value
-$249.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2026 | S · Sale | −9.62K | $26.00 | $249.99K | 10.9% | 88.25K | 78.64K |
| Total | −9.62K | -$249.99K | ||||||
Derivative Transactions0
No derivative transactions reported